Our CEO, José Pereira Leal, makes a compelling case for rebalancing how we fund and value healthcare innovation.
In his latest piece, he argues that diagnostics, and especially in vitro diagnostics (IVDs), are too often overlooked despite being essential to realizing the full promise of precision medicine. From guiding treatment decisions to enabling earlier detection, diagnostics are not a side note: they are central to better, more efficient care.
📖 Read his full article here.
Related Posts
October marked Liver Cancer Awareness Month, a time to spotlight one of the world’s fastest-growing and deadliest cancers: Over 900,000
Ophiomics is heading to Riyadh! We will be attending and exhibiting at the Global Health Exhibition, taking place 27–30 October.
Precision in IVD Tools: How Machine Learning Elevates HepatoDetect for Early HCC Detection Early detection of hepatocellular carcinoma (HCC) in
The most innovative diagnostic test is of little value if it cannot be implemented efficiently in real-world clinical settings. Current
+351 211 369 829 